Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1435.2000 7.30 (0.51%)
NSE Dec 23, 2025 15:31 PM
Volume: 79,812
 

1435.20
0.51%
Karvy
Margin improvement due to product mix and lower overheads: In Q4FY19, total revenues of IPCA Labs increased by 7%YoY to Rs 8338 mn (our estimates Rs 8706 mn) mainly due to increase in domestic formulations and API.
Ipca Laboratories Ltd. has an average target of 1595.00 from 3 brokers.
More from Ipca Laboratories Ltd.
Recommended